aod9604 dosage recommendations December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting AOD-9604 Peptide Guide: Medspa Patient

Overall Health : A persons overall health and the presence of any underlying medical conditions can affect the absorption and utilization of Vitamin B12

Recommended B12 intake is dependent on the level of your deficiency

Dose-response studies: Test multiple dose levels (e.g., 300, 500, 1000 mcg daily) Include a placebo control group Randomize subjects to dose groups Track both efficacy and safety endpoints Use standardized assessment methods Duration studies: Short-term: 48 weeks to assess acute effects Medium-term: 812 weeks for sustained fat loss (most common) Long-term: 1224 weeks for maximum effects and long-term safety Combination studies: Can be combined with other metabolic peptides Consider potential synergies or interactions May use lower doses when combining compounds Track for additive effects or side effects Include single-agent control groups for comparison Tracking parameters: Body weight and body composition (DEXA, BIA, or circumference) Fat mass and lean mass changes Regional fat distribution (waist circumference, imaging) Metabolic markers (glucose, insulin, lipids) Safety parameters (see safety section) Subjective measures (energy, appetite, well-being) Special Considerations Fasting vs fed state: Research suggests AOD9604 may be more effective when administered in a fasted state

Understanding Vitamin B12 and the Nervous System Vitamin B12 is a water-soluble vitamin that plays a crucial role in the production of red blood cells, DNA synthesis, and maintaining brain function

Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man